FdaApplication

ANDA 218242

Back to search

Identifiers

Properties

PropertyValue
applicant_nameFRESENIUS KABI USA LLC
application_typeANDA
approval_date2024-08-15

Products (1)

ProductActive ingredientStrengthDosage form
TRANEXAMIC ACIDTRANEXAMIC ACID1GM/100ML (10MG/ML)SOLUTION;INTRAVENOUS

1 product